WO2004042077A3 - Diagnostics et traitements de maladies associees a la phosphodiesterase 8b humaine (pde8b) - Google Patents
Diagnostics et traitements de maladies associees a la phosphodiesterase 8b humaine (pde8b) Download PDFInfo
- Publication number
- WO2004042077A3 WO2004042077A3 PCT/EP2003/011883 EP0311883W WO2004042077A3 WO 2004042077 A3 WO2004042077 A3 WO 2004042077A3 EP 0311883 W EP0311883 W EP 0311883W WO 2004042077 A3 WO2004042077 A3 WO 2004042077A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorders
- pde8b
- therapeutics
- diagnostics
- diseases associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04053—3',5'-Cyclic-AMP phosphodiesterase (3.1.4.53)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03772262A EP1601782A2 (fr) | 2002-11-08 | 2003-10-25 | Diagnostics et traitements de maladies associees a la phosphodiesterase 8b humaine (pde8b) |
AU2003279323A AU2003279323A1 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02024999 | 2002-11-08 | ||
EP02024999.1 | 2002-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004042077A2 WO2004042077A2 (fr) | 2004-05-21 |
WO2004042077A3 true WO2004042077A3 (fr) | 2005-01-13 |
Family
ID=32309323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/011883 WO2004042077A2 (fr) | 2002-11-08 | 2003-10-25 | Diagnostics et traitements de maladies associees a la phosphodiesterase 8b humaine (pde8b) |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1601782A2 (fr) |
AU (1) | AU2003279323A1 (fr) |
WO (1) | WO2004042077A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101446626B1 (ko) | 2005-09-02 | 2014-10-06 | 도레이 카부시키가이샤 | 신장암 진단, 신장암 환자 예후 예측을 위한 조성물 및 방법 |
US20110045495A1 (en) | 2008-01-17 | 2011-02-24 | Yoshinori Tanaka | Composition and method for diagnosis or detection of renal cancer |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932423A (en) * | 1996-03-25 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterases |
US6080548A (en) * | 1997-11-19 | 2000-06-27 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterases |
WO2000077040A2 (fr) * | 1999-06-16 | 2000-12-21 | Incyte Genomics, Inc. | Molecules de signalisation intracellulaires |
WO2001098471A2 (fr) * | 2000-06-22 | 2001-12-27 | Incyte Genomics, Inc. | Phosphodiesterases |
-
2003
- 2003-10-25 AU AU2003279323A patent/AU2003279323A1/en not_active Abandoned
- 2003-10-25 WO PCT/EP2003/011883 patent/WO2004042077A2/fr not_active Application Discontinuation
- 2003-10-25 EP EP03772262A patent/EP1601782A2/fr not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932423A (en) * | 1996-03-25 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterases |
US6080548A (en) * | 1997-11-19 | 2000-06-27 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterases |
WO2000077040A2 (fr) * | 1999-06-16 | 2000-12-21 | Incyte Genomics, Inc. | Molecules de signalisation intracellulaires |
WO2001098471A2 (fr) * | 2000-06-22 | 2001-12-27 | Incyte Genomics, Inc. | Phosphodiesterases |
Non-Patent Citations (7)
Title |
---|
DATABASE EMBL [online] EBI; 21 December 2000 (2000-12-21), XP002283156, retrieved from EBI Database accession no. AAB64411 * |
DATABASE EMBL [online] EBI; 27 December 2001 (2001-12-27), XP002283155, retrieved from EBI Database accession no. ABB09006 * |
DATABASE EMBL [online] EBI; 27 February 2000 (2000-02-27), XP002283154, retrieved from EBI Database accession no. AAB11938 * |
HAYASHI M ET AL: "Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 250, no. 3, 29 September 1998 (1998-09-29), pages 751 - 756, XP002091362, ISSN: 0006-291X * |
HAYASHI MASAAKI ET AL: "Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 297, no. 5, 11 October 2002 (2002-10-11), pages 1253 - 1258, XP002255295, ISSN: 0006-291X * |
PEREZ-TORRES S ET AL: "Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization.", EXPERIMENTAL NEUROLOGY, vol. 182, no. 2, August 2003 (2003-08-01), pages 322 - 334, XP002283149, ISSN: 0014-4886 * |
See also references of EP1601782A2 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003279323A1 (en) | 2004-06-07 |
EP1601782A2 (fr) | 2005-12-07 |
WO2004042077A2 (fr) | 2004-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004104216A3 (fr) | Diagnostics et agents therapeutiques destines a des maladies liees a une dipeptidylpeptidase iv (dpp4) | |
WO2004042389A3 (fr) | Moyens diagnostiques et therapeutiques destines a des maladies associees a la phosphodiesterase 4d (pde4d) humaine | |
WO2003093816A3 (fr) | Diagnostics et therapeutiques pour lutter contre des maladies associees au recepteur de l'oxytocine (oxtr) | |
WO2004042402A3 (fr) | Moyens diagnostiques et therapeutiques destines a des maladies associees au mrgx1 humain | |
WO2005022164A3 (fr) | Agents diagnostiques et agents therapeutiques destines a des maladies associees a la kallikreine 8 (klk8) | |
WO2004042077A3 (fr) | Diagnostics et traitements de maladies associees a la phosphodiesterase 8b humaine (pde8b) | |
WO2004038405A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 43 couple a la proteine g (gpr43) | |
WO2004071378A3 (fr) | Methodes diagnostiques et therapeutiques relatives a des etats pathologiques lies au recepteur hm74a couple a la proteine g | |
WO2004042390A3 (fr) | Diagnostic et therapeutique de maladies associees a la phosphodiesterase 4b (pde4b) humaine | |
WO2004081563A3 (fr) | Moyens de diagnostic et therapeutiques pour des maladies associees a la phosphodiesterase 1a (pde1a) | |
WO2004029617A3 (fr) | Diagnostic et therapeutique de maladies associees a la phosphodiesterase humaine 11a (pde11a) | |
WO2003096020A3 (fr) | Diagnostic et traitement de maladies liees au recepteur 8 des chimiokines (ccr8) | |
WO2004038421A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees au recepteur 41 couple a une proteine g humaine (gpr41) | |
WO2004038407A3 (fr) | Diagnostics et medicaments pour maladies associees au recepteur 12 humain couple a la proteine g (gpr12) | |
WO2004073587A3 (fr) | Diagnostics et traitements de maladies associees au recepteur de la parathormone 1 (pthr1) | |
WO2003066077A3 (fr) | Outil de diagnostic et therapeutique pour des maladies associees au recepteur de neuromedine u1 (nmu1) | |
WO2004071393A3 (fr) | Diagnostic et therapeutique pour des maladies associees au recepteur peptide 1 de type glucagon | |
WO2004042076A3 (fr) | Diagnostic et therapeutique de maladies associees a la phosphodiesterase 4a (pde4a) humaine | |
WO2003100434A3 (fr) | Diagnostics et therapies pour maladies liees au recepteur 2 de l'arginine vasopressine (avpr2) | |
WO2004042405A3 (fr) | Diagnostic et therapeutique pour maladies associees au recepteur 3 couples aux proteines g (gpr3) humain | |
WO2003100433A3 (fr) | Diagnostics et therapies pour maladies liees au recepteur 3 de l'arginine vasopressine (avpr3) | |
WO2004038416A8 (fr) | Diagnostic et therapeutique de maladies associees au recepteur 6 couple a la proteine g humain (gpr6) | |
WO2004071394A3 (fr) | Agents de diagnostic et de traitement destines aux maladies associees a hm74 (hm74) | |
WO2004050903A3 (fr) | Methodes diagnostiques et therapeutiques concernant des maladies associees a la phosphodiesterase 4c (pde4c) humaine | |
WO2005029086A3 (fr) | Agents diagnostiques et therapeutiques pour des maladies liees au transporteur slc22a10 (ust3-like2) (slc22a10) de cations organiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003772262 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003772262 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |